Anti-allergy medicine EpiPen recall expands to US
- Author: Darren Santiago Apr 02, 2017,
Apr 02, 2017, 1:14
In a release the company says they're being recalled due to two reports of the devices failing to activate outside Canada. That related to two devices - from one lot - failing to activate. The defect occurs rarely and testing did not identify any product lots with a defect.
The affected EpiPens were distributed from between December 17, 2015 to July 2016.
A recall of the emergency anti-allergy medicine EpiPen has been expanded to include Canada, the U.S., Europe, Asia and South America because some of the devices administrating the allergy shots may not work.
EpiPen (0.3 mg epinephrine) auto-injector lot 5GU763, expiry date May 2017. Mylan responded by initiating sales of a so-called authorized generic for $300, but now faces increased competition, as well.
Carl's Jr. Ditches Sexy Ads In New Marketing Campaign
The brands' new tagline is "the great American burger" and instead focuses instead on quality and innovation in fast-food burgers. The elder Hardee will goes up against his son as the two tackle the Jr.'s play boy-like ad campaign while the father was away.
It is important that patients continue to carry their current EpiPen Auto-Injector until they receive a replacement device. To return your product, you can contact Stericycle at 877-650-3494.
Replacement EpiPens can be obtained from your pharmacy, if it has the auto-injector (or its generic equivalent) in stock.
This voluntary recall is being conducted with the knowledge of FDA.
EpiPens are filled with epinephrine, which is injected into a person's thigh to counteract potentially fatal severe allergic reactions.